Immune thrombocytopenic purpura (ITP) may develop during pregnancy or affect later pregnancies. When this occurs, the obstetrician usually seeks the internist for help. The mother and fetus are at serious risk from thrombocytopenia and the measures that can control it. Case reports published since 1950 examine the pathogenesis of ITP and its special problems during pregnancy. Recommendations for management derive from these problems.
Carloss HW, McMillan R, Crosby WH. Management of Pregnancy in Women With Immune Thrombocytopenic Purpura. JAMA. 1980;244(24):2756–2758. doi:10.1001/jama.1980.03310240048027
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: